Simplex Trading’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Sell
735,300
-855,300
-54% -$1.34M ﹤0.01% 4073
2025
Q4
$4.93M Buy
1,590,600
+288,200
+22% +$822K ﹤0.01% 1276
2025
Q3
$3.42M Buy
1,302,400
+770,800
+145% +$1.7M ﹤0.01% 1806
2025
Q2
$653K Buy
531,600
+173,000
+48% +$189K ﹤0.01% 3226
2025
Q1
$394K Buy
358,600
+70,500
+24% +$81.5K ﹤0.01% 3652
2024
Q4
$260K Sell
288,100
-4,200
-1% -$3.6K ﹤0.01% 4226
2024
Q3
$288K Buy
292,300
+131,300
+82% +$126K ﹤0.01% 4172
2024
Q2
$145K Buy
161,000
+41,600
+35% +$31.1K ﹤0.01% 4965
2024
Q1
$140K Sell
119,400
-150,300
-56% -$165K ﹤0.01% 5235
2023
Q4
$246K Sell
269,700
-70,000
-21% -$51.7K ﹤0.01% 4448
2023
Q3
$41K Buy
339,700
+218,600
+181% +$252K ﹤0.01% 5982
2023
Q2
$145K Sell
121,100
-226,600
-65% -$282K ﹤0.01% 4654
2023
Q1
$438K Buy
347,700
+314,700
+954% +$602K ﹤0.01% 3413
2022
Q4
$71K Buy
33,000
+25,500
+340% +$210K ﹤0.01% 5455
2022
Q3
$89K Sell
7,500
-200
-3% -$2.48K ﹤0.01% 5674
2022
Q2
$64K Buy
7,700
+2,800
+57% +$21.7K ﹤0.01% 6167
2022
Q1
$42K Buy
4,900
+500
+11% +$4.82K ﹤0.01% 7378
2021
Q4
$49K Buy
4,400
+3,700
+529% +$43.9K ﹤0.01% 7292
2021
Q3
$5K Hold
700
﹤0.01% 9267
2021
Q2
$5K Buy
700
+682
+3,789% +$5.91K ﹤0.01% 9452
2021
Q1
$16K Sell
18
-2
-10% -$20 ﹤0.01% 7619
2020
Q4
$19K Buy
+20
New +$197 ﹤0.01% 6996
2020
Q3
Sell
-138
Closed -$179K 8044
2020
Q2
$179K Buy
138
+112
+431% +$1.41K ﹤0.01% 4115
2020
Q1
$26K Sell
26
-178
-87% -$2.32K ﹤0.01% 5739
2019
Q4
$318K Sell
204
-83
-29% -$1.67K ﹤0.01% 3223
2019
Q3
$481K Buy
+287
New +$5.71K ﹤0.01% 2659

Other funds holding GOSS

Simplex Trading's GOSS Position: Q1 2024 in Review

Simplex Trading sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 10,505 shares — an estimated $11.6K sold.

Simplex Trading first reported a position in GOSS in Q3 2019 and held it in 13 quarters. The position peaked at $434K in Q1 2020. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Simplex Trading reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 10,505 Gossamer Bio shares in Q1 2024, an estimated $11.6K.
  • Simplex Trading first reported a position in Gossamer Bio in Q3 2019 and held it in 13 quarters.
  • Simplex Trading's Gossamer Bio position peaked at $434K in Q1 2020.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.